References
1. Mahajan VS, Jarolim P. How to interpret elevated cardiac troponin levels. Circulation . 2011;124(21):2350-2354. doi:10.1161/CIRCULATIONAHA.111.023697
2. Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. C Can Med Assoc J . 2005;173(10):1191. doi:10.1503/CMAJ.050141
3. Newby LK, Goldmann BU, Ohman EM. Troponin: An important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol . 2003;41(4 SUPPL. 4):S31-S36. doi:10.1016/s0735-1097(02)02832-2
4. Hamm CW, Ravkilde J, Gerhardt W, et al. The Prognostic Value of Serum Troponin T in Unstable Angina. N Engl J Med . 1992;327(3):146-150. doi:10.1056/NEJM199207163270302
5. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med . 1996;335(18):1342-1349. doi:10.1056/NEJM199610313351802
6. Beller JP, Hawkins RB, Mehaffey JH, et al. Does Preoperative Troponin Level Impact Outcomes After Coronary Artery Bypass Grafting? Ann Thorac Surg . 2018;106(1):46-51. doi:10.1016/j.athoracsur.2018.01.085
7. Matetzky S, Sharir T, Domingo M, et al. Elevated Troponin I Level on Admission Is Associated With Adverse Outcome of Primary Angioplasty in Acute Myocardial Infarction. Circulation . 2000;102(14):1611-1616. doi:10.1161/01.CIR.102.14.1611
8. Heidenreich PA, Alloggiamento T, McDonald KM, Go AS, Hlatky MA, Melsop K. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol . 2001;38(2):478-485. doi:10.1016/S0735-1097(01)01388-2
9. Giannitsis E, Müller-Bardorff M, Lehrke S, et al. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation . 2001;104(6):630-635. doi:10.1161/hc3101.093863
10. Lyon WJ, Baker RA, Andrew MJ, Tirimacco R, White GH, Knight JL. Relationship between elevated preoperative troponin T and adverse outcomes following cardiac surgery. ANZ J Surg . 2003;73(1-2):40-44. doi:10.1046/j.1445-2197.2003.02611.x
11. Thielmann M, Massoudy P, Neuhäuser M, et al. Risk stratification with cardiac troponin I in patients undergoing elective coronary artery bypass surgery☆. Eur J Cardio-Thoracic Surg . 2005;27(5):861-869. doi:10.1016/j.ejcts.2005.01.043
12. Paparella D, Scrascia G, Paramythiotis A, et al. Preoperative Cardiac Troponin I to Assess Midterm Risks of Coronary Bypass Grafting Operations in Patients With Recent Myocardial Infarction. Ann Thorac Surg . 2010;89(3):696-702. doi:10.1016/j.athoracsur.2009.11.072
13. Thielmann M, Massoudy P, Neuhäuser M, et al. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes. Circulation . 2006;114(SUPPL. 1). doi:10.1161/CIRCULATIONAHA.105.001057
14. Buratto E, Conaglen P, Dimitriou J, et al. Predicting adverse outcomes in elective coronary artery bypass graft surgery using pre-operative troponin I levels. Hear Lung Circ . 2014;23(8):711-716. doi:10.1016/j.hlc.2014.03.005
15. Carrier M, Pelletier LC, Martineau R, Pellerin M, Solymoss BC. In elective coronary artery bypass grafting, preoperative troponin T level predicts the risk of myocardial infarction. J Thorac Cardiovasc Surg . 1998;115(6):1328-1334. doi:10.1016/S0022-5223(98)70216-8
16. Thielmann M, Neuhäuser M, Marr A, et al. Predictors and Outcomes of Coronary Artery Bypass Grafting in ST Elevation Myocardial Infarction.Ann Thorac Surg . 2007;84(1):17-24. doi:10.1016/j.athoracsur.2007.03.086
17. Khan AN, Sabbagh S, Ittaman S, et al. Outcome of early revascularization surgery in patients with ST-elevation myocardial infarction. J Interv Cardiol . 2015;28(1):14-23. doi:10.1111/joic.12177
18. Narayan P. Letter to the Editor: “CABG after STEMI”- Is Anytime the Right Time? J Interv Cardiol . 2015;28(4):407-408. doi:10.1111/joic.12207
19. Weiss ES, Chang DD, Joyce DL, Nwakanma LU, Yuh DD. Optimal timing of coronary artery bypass after acute myocardial infarction: A review of California discharge data. J Thorac Cardiovasc Surg . 2008;135(3). doi:10.1016/j.jtcvs.2007.10.042
20. Nichols EL, McCullough JN, Ross CS, et al. Optimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality. In: Annals of Thoracic Surgery . Vol 103. Elsevier USA; 2017:162-171. doi:10.1016/j.athoracsur.2016.05.116
21. Parikh S V., De Lemos JA, Jessen ME, et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients: Results from the national cardiovascular data registry action registry-GWTG (acute coronary treatment and intervention outcomes network registry-get with the guidelines).JACC Cardiovasc Interv . 2010;3(4):419-427. doi:10.1016/j.jcin.2010.01.012
22. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-st-elevation acute coronary syndromes: A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation . 2014;130(25):e344-e426. doi:10.1161/CIR.0000000000000134
Table 1. Preoperative demographics and operative characteristics